Tohoku Chemical Co., Ltd.
FY2026 September Financial Summary [Japanese Standards] (Consolidated)
Revenue was 35,999 million yen (4.5% YoY increase), operating income was 798 million yen (54.0% YoY increase), and net income attributable to owners of parent was 648 million yen (51.2% YoY increase). The outlook for the next fiscal year forecasts lower revenue and profit. Dividends are planned at 140 yen (year-end) and 110 yen for the next fiscal year. By segment, Industry is the core contributor while Medical shows growth.
Key Figures
- Revenue: 35,999,571 thousand yen (YoY 4.5% increase)
- Operating Income: 798,310 thousand yen (YoY 54.0% increase)
- Net Income Attributable to Owners of Parent: 648,130 thousand yen (YoY 51.2% increase)
AI要約
Overview of Performance
For the fiscal year under review, revenue was in the high 35,900 million yen range, representing a 4.5% increase year-on-year. Operating income rose significantly to 79.8 million yen, ordinary income was approximately 90.8 million yen, and net income attributable to owners of parent was approximately 648 million yen, marking substantial profit growth. By segment, Industry contributed the most, and Medical also posted higher revenue and profits. Conversely, Academia & Life Sciences experienced declines in both revenue and profit.
Outlook and Dividends
For the fiscal year ending September 2027, revenue and profits are forecast to decline, based on assumptions including rising energy and resource costs. Dividends are planned at 140 yen at fiscal year-end, and 110 yen for the next fiscal year, maintaining a policy of stable dividends. The company also states its intention to utilize retained earnings to strengthen the financial structure.
Revenue Trend
Operating Income Trend
Net Income Attributable to Owners of Parent Trend
Operating Margin and Ordinary Income Margin Trend
Tohoku Chemical Co., Ltd.
Company overview · Stock price · Financial data · All IR
